We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Somafina, a firm under the umbrella of Heartwood Partners, has acquired UST Corporation, a contract manufacturer specialising in vitamins, minerals, and supplements, for an undisclosed sum. Based in
Eton Pharmaceuticals has launched Nitisinone capsules for the treatment of hereditary tyrosinemia type 1 (HT-1), in conjunction with a diet restricting tyrosine and phenylalanine. Hereditary tyrosinemia type 1
Roche Group has completed the acquisition of Carmot Therapeutics, a clinical-stage biotechnology company committed to advancing transformative therapeutics for individuals grappling with metabolic disorders, such as obesity and
Taiwan-based Formosa Pharmaceuticals has inked a licensing agreement with Cristália Produtos Químicos Farmacêuticos (Cristália) to obtain exclusive rights in Brazil for the commercialisation of APP13007 (clobetasol propionate ophthalmic
GenEdit, a developer of genetic therapies using its NanoGalaxy platform for targeted tissue delivery, has unveiled a long-term collaboration and licensing arrangement with Genentech, an esteemed member of
Alcami, a contract development and manufacturing organisation (CDMO), has finalised the acquisition of Pacific Pharmaceutical Services (PPS), a provider of cGMP pharmaceutical storage and services. In conjunction with
Solid Biosciences has secured orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for SGT-003, the company’s advanced gene therapy candidate for Duchenne muscular dystrophy
Parexel, a clinical research organisation (CRO) offering comprehensive Phase I to IV clinical development services, has entered into a strategic alliance with the Japanese Foundation for Cancer Research
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals have reached an agreement regarding the sale and promotion of Avenova-branded products within the European Union by Sonoma. The upcoming products will integrate
Deepcell, a life science company which brings artificial intelligence to cell biology, has partnered with Nvidia to expedite the advancement and widespread adoption of advanced computer vision solutions